Zhiyun Xu

Dr. Zhiyun Xu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
HXHongjie Xu
Hongjie Xu
YLYang Li
Yang Li
HWHe Wang
He Wang
YYYe Yuan
Ye Yuan
DCDi Chen
Di Chen
ZXZhiyun Xu
Zhiyun Xu

1 November 2020 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
YLYang Li
Yang Li
HJHongxue Jiang
Hongxue Jiang
HXHongjie Xu
Hongjie Xu
NLNing Li
Ning Li
YZYu Zhang
Yu Zhang
ZXZhiyun Xu
Zhiyun Xu

28 May 2023 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
HXHongjie Xu
Hongjie Xu
HWHe Wang
He Wang
LWLujia Wu
Lujia Wu
TXTianyu Xu
Tianyu Xu
LHLin Han
Lin Han
ZXZhiyun Xu
Zhiyun Xu

1 January 2024 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
KHKai Huang
Kai Huang
XSXiaotian Sun
Xiaotian Sun
XXXiangyang Xu
Xiangyang Xu
JLJie Lu
Jie Lu
BZBoyao Zhang
Boyao Zhang
LHLin Han
Lin Han
Background: Pathological cardiac hypertrophy, a condition that contributes to heart failure, is characterized by its intricate pathogenesis. The meticulous regulation of protein function, localization, and degradation is a crucial role played by deubiquitinating enzymes in cardiac pathophysiology. This study clarifies the participation and molecular mechanism of OTUD1 (OTU Deubiquitinase 1) in pathological cardiac hypertrophy.

1 July 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HXHongjie Xu
Hongjie Xu
HWHe Wang
He Wang
SCShisong Chen
Shisong Chen
QCQian Chen
Qian Chen
TXTianyu Xu
Tianyu Xu
YSYangyong Sun
Yangyong Sun
Objective: Though the prognostic value of the model for end-stage liver disease (MELD) score in tricuspid surgery was confirmed, the unstable international normalized ratio (INR) may affect the evaluation effectiveness of the MELD score for isolated tricuspid valve replacement (ITVR). The aim of the study was to assess the prognostic value of modified MELD for ITVR.Methods and Results: A total of 152 patients who underwent ITVR were evaluated. The adverse outcome was defined as in-hospital mortality after surgery. The receiver operating characteristic (ROC) curve analysis demonstrated that a modified MELD score with albumin replacing INR (MELD-albumin) score presented well prognostic value [area under the curve (AUC) = 0.731, p = 0.006] for in-hospital mortality. Through Cox regression and further interval validation, the MELD-albumin score was identified as an independent predictor for in-hospital mortality. The optimal cutoff value of MELD-albumin was identified as 8.58 through maximally selected log-rank statistics. In addition, restricted cubic spline analysis demonstrated the linear inverse relationship between MELD-albumin and hazard ratio (HR) for in-hospital mortality. Kaplan–Meier analysis illustrated that in-hospital mortality was increased significantly in the high MELD-albumin (MELD-albumin ≥8.58) group than in the low MELD-albumin group (MELD-albumin <8.58; p < 0.001). Furthermore, high MELD-albumin was associated with lower body mass index (BMI), the incidence of lower extremities edema and moderate drinking history, and the MELD-albumin score was correlated with the value of aspartate transaminase (AST), alanine transaminase (ALT), and albumin. Furthermore, the incidence of renal failure (p = 0.003) and pulmonary infection (p = 0.042) was increased significantly in the high MELD-albumin group.Conclusion: The MELD-albumin score could provide prognostic value for ITVR. In addition, the MELD-albumin score was useful in risk stratification and patient selection for patients with tricuspid regurgitation (TR) prior to ITVR.

6 April 2024 in Journal of Cardiology
Verified
Journal Article
Closed access
XNXiaoping Ning
Xiaoping Ning
HXHongjie Xu
Hongjie Xu
JCJingyi Cao
Jingyi Cao
NLNing Li
Ning Li
WWWei Wang
Wei Wang
ZXZhiyun Xu
Zhiyun Xu